https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/a-phase-ii-and-phase-iii-peri-operative-trial-of
A Phase II and Phase III Peri-Operative Trial of Fianlimab and Cemiplimab Compared with Anti-PD1...
A Phase II and Phase III Peri-Operative Trial of Fianlimab and Cemiplimab Compared with Anti-PD1 Alone in Patients with Resectable Stage III and IV Melanoma